Ativo Circulante Alterar Data
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Assertio Holdings USD 263.57M 53.36M 2025-09
Aurora Cannabis CAD 445.84M 22M 2025-12
Cara Therapeutics USD 43.13M 4.18M 2025-06
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
J&J USD 55.62B 1.01B 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 46.92B 3.22B 2025-09
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12